Warm congratulations on the successful hosting of the Tenth National Academic Conference on Endoscop
Warm congratulations on the successful hosting of the Tenth National Academic Conference on Endoscopic Minimally Invasive Gallbladder-Preserving Surgery at our hospital
Dear experts and colleagues,
In September in Lanzhou, by the banks of the Yellow River, a crisp autumn breeze brings refreshment. In this delightful season, the Tenth National Academic Conference on Endoscopic Minimally Invasive Gallbladder-Preserving Surgery is about to grandly commence. We warmly look forward to experts and colleagues joining us for this feast of academic and cultural exchange. On behalf of the conference organizing committee, I extend the warmest welcome and most sincere thanks to all the experts and scholars who have come from afar, and to the colleagues who have long been dedicated to the field of endoscopic minimally invasive gallbladder preservation and have poured their efforts into the discipline's development.
The river of medical development surges forward. The field of endoscopic minimally invasive gallbladder preservation, pioneered by Professor Zhang Baoshan, a trailblazer in China's minimally invasive gallbladder-preserving cause, has become one of the most luminous beacons in the treatment of gallstone disease. Looking back, under the guidance of the National Minimally Invasive Gallbladder-Preserving Professional Committee, we have overcome difficulties together, explored mysteries in the depths of basic research, pursued precision in the details of surgical standardization, and made continuous breakthroughs in preventing postoperative recurrence. Today, the concept of "standardized gallbladder preservation" is like a spring rain, moistening the original aspiration of every medical practitioner. We adhere to the medical truth of preserving organ function and maintaining bodily integrity, bringing hope of life and dawn of health to countless patients.
It is particularly exciting that, approved by the higher-level society, the Minimally Invasive Gallbladder-Preserving Professional Committee is soon to be upgraded to the Endoscopic Minimally Invasive Gallbladder-Preserving Branch! Additionally, the Chinese Anti-Cancer Association's Professional Committee on Tumors and Gallbladder Protection will be established. This is not only high recognition of our past efforts but also bestow upon us a new mission and responsibility, marking the entry of the endoscopic minimally invasive gallbladder-preserving cause into a new stage full of greater vitality and potential.
This academic conference is a hall for the blending of wisdom and a starting point for marching forward together. We have invited many top domestic experts who will share cutting-edge academic achievements and valuable clinical experiences; meticulously arranged surgical video exhibitions and live demonstrations will leave no technical detail hidden; the rich and diverse academic topics cover everything from basic research to clinical practice. We look forward to every participant speaking freely and engaging in deep exchange here, jointly overcoming technical challenges and exploring new paths for disciplinary development.
Dear colleagues, the development of the endoscopic minimally invasive gallbladder-preserving cause relies on the persistence and innovation of each individual. Let us take this conference as an opportunity to build consensus, join hands, and stand shoulder to shoulder, using our professionalism and enthusiasm to write a new chapter for the gallbladder-preserving cause, contributing more wisdom and strength to protect the health of the people's liver and gallbladder!
Finally, we wish this conference complete success! We wish all experts and colleagues a rewarding journey in this academic endeavor, good health, and all the best!
Conference Organizational Structure
Conference Information
Conference Agenda
Time: All day on September 5th
Check-in Locations:
1.VIPs: Jinchuan Group Lanzhou Hotel (No. 5109 Yanxia Road, Chengguan District, Lanzhou City)
2.Guests and general representatives: Lanzhou Yellow River Meihua Hotel (No. 18 Yanbei Road, Chengguan District, Lanzhou City)
Meeting Time: September 5th to September 7th
Meeting Location:
Gansu Wuwei Tumor Hospital Lanzhou Heavy Ion Center Conference Room (No. 100 Yanbei Road, Chengguan District, Lanzhou City)
Hotel Accommodations:
1.Lanzhou Yellow River Meihua Hotel (No. 18 Yanbei Road, Chengguan District, Lanzhou City)
2.Jinchuan Group Lanzhou Hotel (No. 5109 Yanxia Road, Chengguan District, Lanzhou City)
If room booking is required, the organizing committee can assist with arrangements.
Fees:
The registration fee for this conference is 600 yuan (waived for participants from grassroots institutions in western regions). Transportation and accommodation expenses are to be covered individually. The registration fee is waived for participants from grassroots institutions in western regions.
Contact Information:
Contacts:
Zhang Qiong Tel: +86 18919901005
Qiao Jianli Tel: +86 18993148118
Yang Lixia Tel: +86 13809356120
If you have any questions regarding the lecture content or require additional information, please feel free to contact us.
Contacts:
Lu Jizhou Tel: +86 15117256166
Xing Wenjun Tel: +86 13909352675
甘肃省武威肿瘤医院肝胆外二科(肝胆中心)简介
甘肃省武威肿瘤医院肝胆中心肝胆外二科，专注肝胆脾胰疾病诊疗，以专业团队、先进理念与特色技术，在肿瘤防治及肝胆疾病诊疗领域深耕细作，守护患者健康。武威医科院肝胆中心是由市卫健委批准命名的以肝胆疾病内科、外科、微创、介入等多学科组建的单病种中心，目前设立床位160张，内有普通病房、外科病房、微创病房、人工肝治疗室、肝病实验室、随访办公室、重症监护室、乙肝临床治愈门诊等。
Introduction to the Hepatobiliary Surgery II Department (Hepatobiliary Center) of Gansu Wuwei Cancer Hospital
The Hepatobiliary Surgery II Department of the Hepatobiliary Center at Gansu Wuwei Cancer Hospital specializes in the diagnosis and treatment of hepatic, biliary, splenic, and pancreatic diseases. It is dedicated to the prevention and treatment of tumors and various hepatobiliary conditions through a professional team, advanced ethos, and specialized techniques, all focused on safeguarding patient health. The Hepatobiliary Center of Wuwei Medical Academy is a single-disease center approved and named by the Municipal Health Commission, integrating multiple disciplines such as internal medicine for liver diseases, surgery, minimally invasive techniques, and interventional therapy. It currently has 160 beds, including general wards, surgical wards, minimally invasive wards, an artificial liver treatment room, a liver disease laboratory, a follow-up office, an intensive care unit, and a hepatitis B clinical cure outpatient clinic.
邢文军主任
I. Professional Team: Skilled and Technically Proficient, Providing Escort for Health
The department brings together numerous senior experts and mid-career key physicians. All members have undertaken advanced studies and training in renowned domestic hospitals, mastering cutting-edge diagnostic and therapeutic technologies for hepatic, biliary, splenic, and pancreatic diseases. Emphasis is placed on talent cultivation and academic exchange. Regular case discussions, technical training, and interdisciplinary communications are conducted to continuously enhance the overall medical proficiency of the team, laying a solid foundation for high-quality diagnosis and treatment, and ensuring escort for patient health.
II. Whole-Process Single-Disease Treatment: One-Stop Guardian for Liver and Gallbladder Health
Adhering to advanced diagnostic and treatment理念, the department implements a whole-process single-disease treatment model for benign and malignant diseases of the liver, gallbladder, spleen, and pancreas. It provides "one-stop" medical services for patients, ranging from early screening and precise diagnosis to the formulation of personalized treatment plans, and further to postoperative rehabilitation management and follow-up:
● Early Screening: Utilizing advanced equipment such as PET-CT, 3.0T MRI, and dynamic 500-slice gemstone spectral CT, combined with tumor marker detection, to achieve "early detection" of diseases.
● Precise Diagnosis and Treatment: Through the collaboration of a Multidisciplinary Expert Team (MDT), personalized treatment plans are tailored according to the patient's condition and physical status, encompassing surgery, radiotherapy and chemotherapy, interventional therapy, targeted therapy, and more.
● Postoperative Management: Through comprehensive rehabilitation plans and close follow-up, patients are assisted in rapid recovery, potential issues are addressed promptly, and long-term health is safeguarded.
III. Featured Technologies: Specializing in Complex Cases with Precision Treatment
1. Gallbladder-Preservation Techniques: Safeguarding Gallbladder Function
The department performs robot-assisted and single-port dual-endoscopy combined gallbladder-preserving stone and polyp removal surgeries. Unlike traditional gallbladder removal approaches, these techniques completely extract stones and polyps while preserving the gallbladder's normal physiological function. Utilizing high-definition endoscopes, laparoscopes, and other equipment, the department achieves precise lesion localization and minimally invasive operations, resulting in quick postoperative recovery. This meets patients' needs for preserving gallbladder function, particularly benefiting those with good gallbladder function suffering from stones or polyps. The department has safely completed over 150 cases of various ultra-minimally invasive and robot-assisted gallbladder-preserving stone and polyp removal surgeries, with patients recovering well postoperatively and no complications reported. The gallbladder-preservation technology ranks among the forefront in the Hexi region. The department head and academic leader, Xing Wenjun, serves as the Vice Chairman of the Gansu Provincial Association of Endoscopic Minimally Invasive Gallbladder Preservation. 6
2.Complex Bile Duct and Pancreatic Duct Stones: Overcoming Surgical Challenges
The department has extensive experience in managing complex bile duct stones and pancreatic duct stones. Using ultra-slim choledochoscopes, PTCL, PTCS, ERCP, extracorporeal ultrasonic lithotripsy, combined laparoscopic surgery, and techniques such as intraoperative ultrasound and cholangiography, the team accurately locates intrahepatic and extrahepatic bile duct stones. They flexibly employ approaches like percutaneous transhepatic intrahepatic bile duct stone removal, ERCP, bile duct incision for stone extraction, and cholangiojejunostomy to effectively clear complex stone distributions, relieve biliary and pancreatic duct obstructions, and reduce recurrence risks. This provides effective treatment solutions for patients with challenging bile duct and pancreatic duct stones. The department has performed PTCL treatment on a patient with intrahepatic bile duct stones and common bile duct stones who had undergone nine previous surgeries. The patient was able to ambulate on the same day after treatment and was discharged the next day.
3. Complex Liver Tumor Surgery: Precision Liver Resection
The department is equipped with advanced technology such as domestic four-arm robots, 4K laparoscopes, and fluorescence laparoscopes. With high-definition, precise visual presentation and operational assistance, surgeries are less traumatic, involve less bleeding, promise faster recovery, and shorter hospital stays. The team is proficient in performing robot-assisted and laparoscopic precision liver segment resection, hemihepatectomy, central hepatectomy, and other complex procedures. Leveraging in-depth knowledge of liver anatomy, they ensure complete tumor removal while preserving as much normal liver tissue as possible, reducing surgical risks. For challenging cases like large liver cancers and hilar liver cancers, multidisciplinary collaboration is employed to develop treatment plans, improving surgical success rates and patient survival. The department also has specialized experience in treating alveolar and cystic hydatid disease, routinely performing hydatid cyst outer plate (resection).
4. Pancreatic Disease Surgery: Integrating Minimally Invasive and Comprehensive Therapy
The department routinely performs high-difficulty surgeries such as laparoscopic pancreaticoduodenectomy and duodenum-preserving pancreatic head resection. For pancreatic cancer, a comprehensive treatment strategy of "surgery + intraoperative radiotherapy/postoperative chemotherapy" is promoted. Emphasis is placed on surgical details and postoperative management. Using laparoscopic minimally invasive techniques, trauma is reduced while effectively controlling complications such as pancreatic fistula and infection, thereby improving patients' quality of life.
5. Interventional Therapy Techniques: Minimally Invasive Tumor Control with Diverse Applications
The department routinely performs interventional treatments such as transarterial chemoembolization (TACE), hepatic arterial infusion chemotherapy (HAIC), percutaneous transhepatic cholangial drainage (PTCD), and radioactive seed implantation for malignant liver and pancreatic tumors. For inoperable liver cancer, bile duct cancer, and pancreatic cancer, precise vascular puncture is used to embolize tumor-feeding arteries and drain bile ducts, effectively controlling tumor growth and alleviating symptoms. Additionally, interventional techniques are applied to treat benign conditions like splenomegaly and hepatic hemangiomas, expanding diagnostic and treatment boundaries and providing patients with more options.
6. Heavy Ion Therapy Auxiliary Technology: Ensuring Precision and Safety
The department actively participates in collaborative diagnosis and treatment for heavy ion therapy. For some patients undergoing heavy ion therapy, they perform surgical placement of Spacer technology between organs and tumors. Here, "Spacer" specifically refers to isolation materials (such as medical gauze pads or specialized materials) used during surgery to create a physical barrier between the tumor and critical organs (e.g., gastrointestinal tract, spinal cord, heart), ensuring the precision and safety of heavy ion therapy. Through precise intraoperative manipulation, effective isolation is established between the tumor and surrounding normal tissues, reducing damage to normal organs from heavy ion irradiation. This safeguards heavy ion therapy for patients with tumors in special locations, further enhancing the safety and precision of the treatment.
The Second Department of Hepatobiliary Surgery remains patient-centered, relying on advanced equipment and technology(expertise) to deeply engage in the diagnosis and treatment of hepatobiliary diseases. They continuously improve technology and services, building a robust health defense for patients with liver, gallbladder, spleen, and pancreatic diseases in the Longyuan region, helping more families regain the beauty of life.
Preliminary Review: Zhang Lihong Final Review: Zhang Jie